Trial · NCT07909564
Ring Fit Adventure for Functional Decline and Fall Risk in Community-Dwelling Older Adults
NCT07909564, Not applicable, Recruiting, Tungs' Taichung Metroharbour Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ring Fit Adventure for Functional Decline and Fall Risk in Community-Dwelling Older Adults. Trials, record NCT07909564. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07909564
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ring Fit Adventure for Functional Decline and Fall Risk in Community-Dwelling Older Adults
- NCT number
- NCT07909564
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Tungs' Taichung Metroharbour Hospital
- Conditions
- Functional Decline
- Interventions
- Ring Fit Adventure-based Exercise Program
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Balance performance measured by Brief-BESTest | Baseline, Week 8, Week 12, and Week 24 | Balance performance will be assessed using the Brief Balance Evaluation Systems Test (Brief-BESTest), which evaluates 6 domains of postural control. Each item is scored from 0 to 3, with a total score ranging from 0 to 24. Higher scores indicate better balance performance. |
| Secondary | Cognitive function measured by Montreal Cognitive Assessment | Baseline, Week 8, Week 12, and Week 24 | Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA). The total score ranges from 0 to 30, with higher scores indicating better cognitive function. |
| Secondary | Attendance rate | During the 8-week intervention period | Attendance will be assessed as the number of completed intervention sessions out of the total planned sessions during the 8-week intervention period. |
| Secondary | Adherence to the intervention | During the 8-week intervention period | Adherence will be defined as attendance at at least 80% of the planned intervention sessions. |
| Secondary | Completion rate | Up to Week 24 | Completion will be assessed as the proportion of participants who complete the intervention program and follow-up assessments. |
| Secondary | Acceptability measured by RFA-AFSPEQ | Week 8 | Acceptability will be assessed using the self-designed Ring Fit Adventure Acceptability, Feasibility, Safety, and Participation Experience Questionnaire (RFA-AFSPEQ). Higher scores indicate greater acceptance of the intervention. |
| Secondary | The 5-item Brief Symptom Rating Scale (BSRS-5) | Baseline, Week 8, Week 12, and Week 24 | It serves as an assessment of psychological distress and mental health status. Each item is evaluated using a 5-point Likert scale ranging from 0 ("not at all") to 4 ("extremely"). |
| Other | Change in heart rate | During the 8-week intervention period | Heart rate will be measured in beats per minute (bpm) before and after each intervention session. For each session, the within-session change will be calculated as the post-session value minus the pre-session value. The reported value is the average of these within-session changes across the 8 weeks interven. Positive values indicate an increase in heart rate after the session. |
| Other | Change in peripheral oxygen saturation | During the 8-week intervention period | Peripheral oxygen saturation will be measured as a percentage (%) before and after each intervention session. The reported value will be the mean change from pre-session to post-session peripheral oxygen saturation during the 8-week intervention period. |
| Other | Change in systolic blood pressure | During the 8-week intervention period | Systolic blood pressure will be measured in mmHg before and after each intervention session. The reported value will be the mean change from pre-session to post-session systolic blood pressure during the 8-week intervention period. |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers14
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07909564
GET https://conductscience.org/api/trials/v1/NCT07909564/registered